161 related articles for article (PubMed ID: 26590370)
21. [Overexpression of the receptor tyrosine kinase EphA2 in choroidal melanoma: correlation with vesculogenic mimicry and prognosis].
Chen LX; Sun BC; Li XR; He YJ; Song GX
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):985-90. PubMed ID: 23302271
[TBL] [Abstract][Full Text] [Related]
22. Expression of Caveolin-1 in Human Cutaneous and Uveal Melanoma Cells.
Belkot K; Bubka M; Litynska A
Folia Biol (Krakow); 2016; 64(3):145-151. PubMed ID: 29847075
[TBL] [Abstract][Full Text] [Related]
23. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
[TBL] [Abstract][Full Text] [Related]
24. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
Bhat P; Jakobiec FA; Folberg R
Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing fibrovascular septa from vasculogenic mimicry patterns.
Lin AY; Maniotis AJ; Valyi-Nagy K; Majumdar D; Setty S; Kadkol S; Leach L; Pe'er J; Folberg R
Arch Pathol Lab Med; 2005 Jul; 129(7):884-92. PubMed ID: 15974811
[TBL] [Abstract][Full Text] [Related]
26. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
27. Expression of c-Kit and its ligand SCF in primary uveal melanoma.
Lüke J; Wegner J; Wegner R; Nassar K; Tatar O; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Eur J Ophthalmol; 2011; 21(5):615-24. PubMed ID: 21279973
[TBL] [Abstract][Full Text] [Related]
28. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma.
Sabazade S; Gill V; Herrspiegel C; Stålhammar G
J Cancer Res Clin Oncol; 2022 Mar; 148(3):587-597. PubMed ID: 34775516
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
31. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
32. Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.
Suesskind D; Paulsen F; Buchgeister M; Spitzer B; Rohrbach JM; Bartz-Schmidt KU; Spitzer MS
Acta Ophthalmol; 2010 Aug; 88(5):582-7. PubMed ID: 19432844
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma.
Scholes AG; Hagan S; Hiscott P; Damato BE; Grierson I
Arch Ophthalmol; 2001 Mar; 119(3):373-7. PubMed ID: 11231770
[TBL] [Abstract][Full Text] [Related]
34. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
35. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of legumain in uveal melanoma.
Wu T; Sun L; Wu Y; Xiang R; Li Y; Rong W; Sun F; Wang N
Mol Med Rep; 2016 Mar; 13(3):2377-84. PubMed ID: 26846877
[TBL] [Abstract][Full Text] [Related]
37. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW
Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537
[TBL] [Abstract][Full Text] [Related]
38. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
[TBL] [Abstract][Full Text] [Related]
39. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
40. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
